Inside Precision Medicine

A breast cancer’s molecular subtype can help guide treatment, but it does not always predict how well a patient will respond. New research suggests that factors beyond tumor genetics, including interactions with surrounding nerves and immune cells, could provide additional clues for personalizing therapy.

In a study published in the 

As one of the world’s most common genetic diseases, developing treatments for autosomal dominant polycystic kidney disease (ADPKD) is both a daunting and important task. Much research has been done to develop strategies that not only treat symptoms of ADPKD, but also show promise in reversing the growth of cysts that are a hallmark of the disease. As the disease progresses, t...

Researchers in the U.K. have found a previously unknown mechanism that allows Candida auris to resist antifungal drugs. Published today in Nature Communications, their findings show that the fungus makes 2–4 copies of its entire genome, including mutation...

Chinese researchers have identified a key molecular driver that could be targeted in an attempt to prevent osteoporosis.

The findings, in Advanced Science, suggest interrupting this inflammation-related signaling pathway together with the u...

BOSTON, October 8, 2026—“How many people have gotten their whole genome sequenced?” Ten hands went up. 

“How many people would get their whole genome sequenced today?” Twenty hands went up.

Then came the inverse question. “How many people would not want their whole genome sequenced, even if it was free?” Thirt...